The author argues UNH is not a value investment due to CMS Medicare rate increases being insufficient to offset rising medical costs, leading to margin compression in Medicare Advantage.
UNH — AVOID The author argues UNH is not a value investment because its Medicare Advantage margins depend on CMS rate increases of ~6%+ annually, but CMS only delivered ~0.9% while medical costs remain elevated. This mismatch compresses margins and forces UNH to rely on flawless execution in cost control and risk adjustment, a structural shift that has historically killed or forced consolidation among insurers. The author does not predict UNH's demise but warns that gravity eventually wins when margins compress, and the stock may already be back to square one. The main stated risk is that the stock can keep rising even as the underlying business weakens, making the thesis vulnerable to momentum.
UNH--and much of the Medicare Advantage space--was highly dependent on CMS delivering a \~6%+ annual rate increase. Without that, the math breaks.
This Reddit post, published February 04, 2026, features u/Rainyfriedtofu discussing UNH. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Rainyfriedtofu · Tickers: UNH